NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
Want to see NMTC full AI Analyst Report?
Total Valuation
NeuroOne Medical Technologies has a market cap or net worth of $31.81M. The enterprise value is $29.21M.
Market Cap$31.81M
Enterprise Value$29.21M
Share Statistics
NeuroOne Medical Technologies has 8,619,876 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,619,876
Owned by Insiders34.22%
Owned by Institutions―
Financial Efficiency
NeuroOne Medical Technologies’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -49.11%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-49.11%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee711.63K
Profits Per Employee-212.08K
Employee Count17
Asset Turnover1.12
Inventory Turnover1.78
Valuation Ratios
The current PE Ratio of NeuroOne Medical Technologies is ―. NeuroOne Medical Technologies’s PEG ratio is 0.12.
PE Ratio―
PS Ratio2.95
PB Ratio5.04
Price to Fair Value5.04
Price to FCF-12.22
Price to Operating Cash Flow-4.19
PEG Ratio0.12
Income Statement
In the last 12 months, NeuroOne Medical Technologies had revenue of 12.10M and earned -3.61M in profits. Earnings per share was -0.54.
Revenue12.10M
Gross Profit8.14M
Operating Income-4.23M
Pretax Income-3.61M
Net Income-3.61M
EBITDA-3.01M
Earnings Per Share (EPS)-0.54
Cash Flow
In the last 12 months, operating cash flow was -7.43M and capital expenditures -133.43K, giving a free cash flow of -7.57M billion.
Operating Cash Flow-7.43M
Free Cash Flow-7.57M
Free Cash Flow per Share-0.88
Dividends & Yields
NeuroOne Medical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.51
52-Week Price Change-1.26%
50-Day Moving Average4.53
200-Day Moving Average4.71
Relative Strength Index (RSI)35.58
Average Volume (3m)532.45K
Important Dates
NeuroOne Medical Technologies upcoming earnings date is Aug 19, 2026, Before Open (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
NeuroOne Medical Technologies as a current ratio of 4.44, with Debt / Equity ratio of 3.85%
Current Ratio4.44
Quick Ratio3.47
Debt to Market Cap0.00
Net Debt to EBITDA2.09
Interest Coverage Ratio-12.65
Taxes
In the past 12 months, NeuroOne Medical Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NeuroOne Medical Technologies EV to EBITDA ratio is -9.76, with an EV/FCF ratio of -10.06.
EV to Sales2.43
EV to EBITDA-9.76
EV to Free Cash Flow-10.06
EV to Operating Cash Flow-10.35
Balance Sheet
NeuroOne Medical Technologies has $2.80M in cash and marketable securities with $206.97K in debt, giving a net cash position of $2.60M billion.
Cash & Marketable Securities$2.80M
Total Debt$206.97K
Net Cash$2.60M
Net Cash Per Share$0.30
Tangible Book Value Per Share$1.05
Margins
Gross margin is 54.50%, with operating margin of -34.94%, and net profit margin of -29.80%.
Gross Margin54.50%
Operating Margin-34.94%
Pretax Margin-29.80%
Net Profit Margin-29.80%
EBITDA Margin-24.88%
EBIT Margin-27.04%
Analyst Forecast
The average price target for NeuroOne Medical Technologies is $9.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.67
Price Target Upside99.72% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast10.98%
EPS Growth Forecast41.82%